Official Gene Symbol | Other Aliases |
---|---|
Serpina3g | Spi2A |
Sequence Length (AA) | Molecular Weight (Da) |
---|---|
440 | 49021 |
Protein Name |
---|
Serine protease inhibitor A3G |
Sources | |
---|---|
UniProt PhosphoSitePlus ® GeneCards |
Human Protein Atlas |
10 | 20 | 30 | 40 | 50 |
MAGVSPAVFG | CPDVTLGRNT | AVREVQENVT | SVDSLTLVSS | NTDFAFSLYR |
60 | 70 | 80 | 90 | 100 |
KLVLKNPDEN | VVFSPFSICT | ALALLSLGAK | SNTLKEILEG | LKFNLTETPE |
110 | 120 | 130 | 140 | 150 |
PDIHQGFRYL | LDLLSQPGNQ | VQISTGSALF | IEKHLQILAE | FKEKARALYQ |
160 | 170 | 180 | 190 | 200 |
AEAFTADFQQ | PLKATKLIND | YVSNHTQGKI | KELISGLKES | TLMVLVNYIY |
210 | 220 | 230 | 240 | 250 |
FKGKWKNPFD | PNDTFKSEFY | LDEKRSVIVS | MMKTGYLTTP | YFRDEELSCT |
260 | 270 | 280 | 290 | 300 |
VVELKYTGNA | SAMFILPDQG | RMQQVEASLQ | PETLRKWKNS | LKPRMIHELR |
310 | 320 | 330 | 340 | 350 |
LPKFSISTDY | SLEHILPELG | IREVFSTQAD | LSAITGTKDL | RVSQVVHKAV |
360 | 370 | 380 | 390 | 400 |
LDVAETGTEA | AAATGMAGVG | CCAVFDFLEI | FFNRPFLMII | SDTKAHIALF |
410 | 420 | 430 | 440 | |
MAKVTNPERS | MNFPNGEGAS | SQRLESKRLC | FGDPLCLIGQ |
Data source: UniProt
Uniprot Database Entry PhosphoSitePlus ®
loading
Data source: Panorama
Data source: Panorama
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
b7 (1+) | 22 | 17.4 | 8 | 31.5 | 21.2 | 9.3 | 38.4 | 27.4 | 12.3 | 15 | 15 | 15 |
b4 (1+) | 15.1 | 10.8 | 10.4 | 16.5 | 14.4 | 11.4 | 22.4 | 18 | 15.4 | 15 | 15 | 15 |
y3 (1+) | 5.7 | 5.3 | 4 | 12.5 | 7 | 5.6 | 13.7 | 8.8 | 6.9 | 15 | 15 | 15 |
y6 (1+) | 13.7 | 6.2 | 9.1 | 11.8 | 9.8 | 10 | 18.1 | 11.6 | 13.5 | 15 | 15 | 15 |
y8 (1+) | 20.1 | 10.3 | 6.7 | 17.8 | 12.5 | 7.1 | 26.8 | 16.2 | 9.8 | 15 | 15 | 15 |
sum | 6.6 | 2.9 | 2.6 | 10.2 | 6.9 | 4.6 | 12.1 | 7.5 | 5.3 | 15 | 15 | 15 |
Comments